Completed PHASE4 INTERVENTIONAL NCT00479908

Blood Pressure Interaction Between Sildenafil and Sublingual Glyceryl Trinitrate (GTN) in Men With Angina

Investigation of the Time Course of the Interaction of the Hypotensive Effects of Sildenafil Citrate and Sublingual Glyceryl Trinitrate (GTN) in Men With Stable Angina Pectoris

Sponsor: Pfizer

Conditions Angina Pectoris

Interventions Glyceryl trinitrate Sildenafil citrate

Updated 5 times since 2017 Last updated: May 29, 2007 Started: Jan 31, 2004 Completion: Sep 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Angina Pectoris, this trial is completed. The trial is conducted by Pfizer and has accumulated 5 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pfizer
University of Edinburgh

Data source: University of Edinburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Edinburgh, United Kingdom